357 related articles for article (PubMed ID: 19375096)
1. Bother related to bladder control and health care seeking behavior in adults in the United States.
Benner JS; Becker R; Fanning K; Jumadilova Z; Bavendam T; Brubaker L;
J Urol; 2009 Jun; 181(6):2591-8. PubMed ID: 19375096
[TBL] [Abstract][Full Text] [Related]
2. Symptom bother and health care-seeking behavior among individuals with overactive bladder.
Irwin DE; Milsom I; Kopp Z; Abrams P;
Eur Urol; 2008 May; 53(5):1029-37. PubMed ID: 18243515
[TBL] [Abstract][Full Text] [Related]
3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
4. National community prevalence of overactive bladder in the United States stratified by sex and age.
Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
[TBL] [Abstract][Full Text] [Related]
5. Predictors of discontinuing overactive bladder medications.
Brubaker L; Fanning K; Goldberg EL; Benner JS; Trocio JN; Bavendam T; Jumadilova Z
BJU Int; 2010 May; 105(9):1283-90. PubMed ID: 19912189
[TBL] [Abstract][Full Text] [Related]
6. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.
Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS
Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported reasons for discontinuing overactive bladder medication.
Benner JS; Nichol MB; Rovner ES; Jumadilova Z; Alvir J; Hussein M; Fanning K; Trocio JN; Brubaker L
BJU Int; 2010 May; 105(9):1276-82. PubMed ID: 19912188
[TBL] [Abstract][Full Text] [Related]
8. Urinary incontinence and overactive bladder in patients with heart failure.
Palmer MH; Hardin SR; Behrend C; Collins SK; Madigan CK; Carlson JR
J Urol; 2009 Jul; 182(1):196-202. PubMed ID: 19447424
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and burden of overactive bladder in the United States.
Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ
World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491
[TBL] [Abstract][Full Text] [Related]
10. Impact of overactive bladder on women in the United States: results of a national survey.
Dmochowski RR; Newman DK
Curr Med Res Opin; 2007 Jan; 23(1):65-76. PubMed ID: 17257467
[TBL] [Abstract][Full Text] [Related]
11. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
12. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS.
Sexton CC; Coyne KS; Kopp ZS; Irwin DE; Milsom I; Aiyer LP; Tubaro A; Chapple CR; Wein AJ;
BJU Int; 2009 Apr; 103 Suppl 3():12-23. PubMed ID: 19302498
[TBL] [Abstract][Full Text] [Related]
13. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry.
Mahajan ST; Patel PB; Marrie RA
J Urol; 2010 Apr; 183(4):1432-7. PubMed ID: 20171697
[TBL] [Abstract][Full Text] [Related]
14. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
15. Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking.
Yu HJ; Liu CY; Lee KL; Lee WC; Chen TH
Urol Int; 2006; 77(4):327-33. PubMed ID: 17135783
[TBL] [Abstract][Full Text] [Related]
16. Health-related consequences of overactive bladder.
Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
18. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
[TBL] [Abstract][Full Text] [Related]
20. Validation of the overactive bladder symptom score.
Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C
J Urol; 2007 Aug; 178(2):543-7; discussion 547. PubMed ID: 17570417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
